BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 6675522)

  • 1. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC; Herrmann W
    Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
    Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of very early pregnancy by RU 486--an antiprogestational compound.
    Kovacs L; Sas M; Resch BA; Ugocsai G; Swahn ML; Bygdeman M; Rowe PJ
    Contraception; 1984 May; 29(5):399-410. PubMed ID: 6744860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
    Das C; Catt KJ
    Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist.
    Maria B; Stampf F; Goepp A; Ulmann A
    Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy].
    Herrmann W; Wyss R; Riondel A; Philibert D; Teutsch G; Sakiz E; Baulieu EE
    C R Seances Acad Sci III; 1982 May; 294(18):933-8. PubMed ID: 6814714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy termination with a high and medium dosage regimen of RU 486.
    Shoupe D; Mishell DR; Brenner PF; Spitz IM
    Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal contraception.
    Yen S; Garzo G; Liu J
    Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M; Van Look PF
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.